Viewing Study NCT02593227


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT02593227
Status: COMPLETED
Last Update Posted: 2021-07-19
First Post: 2015-10-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer
Sponsor: Marker Therapeutics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-04
Start Date Type: ACTUAL
Primary Completion Date: 2021-07-15
Primary Completion Date Type: ACTUAL
Completion Date: 2021-07-15
Completion Date Type: ACTUAL
First Submit Date: 2015-10-27
First Submit QC Date: None
Study First Post Date: 2015-11-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-07-15
Last Update Post Date: 2021-07-19
Last Update Post Date Type: ACTUAL